The impact of balanced hydroxylethyl starch cardiopulmonary bypass priming solution on the fibrin part of clot formation: Ex vivo rotation thromboelastometry

Perfusion

Volumn 26, Issue 3, 2011, Pages 175-180

  Appelman, Marly H ^a   Van Barneveld, Lerau J M ^a   Romijn, Johannes W A ^a   AVonk, Alexander B ^a   Boer, Christa ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Balanced colloid solution; Coagulation; Dilution; Fibrinogen; Priming solution

Indexed keywords

FIBRIN; FIBRINOGEN; GELATIN SUCCINATE; GELOFUSIN; HETASTARCH; TETRASPAN; UNCLASSIFIED DRUG;

ADULT; ALPHA ANGLE; ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD EXAMINATION; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; EX VIVO STUDY; EXPLORATORY RESEARCH; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM CLOT FIRMNESS; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOELASTOMETRY;

BLOOD COAGULATION; CARDIOPULMONARY BYPASS; FEMALE; FIBRIN; GELATIN; HEMOSTASIS, SURGICAL; HETASTARCH; HUMANS; MALE; PLASMA SUBSTITUTES; THROMBELASTOGRAPHY;

EID: 79960163264     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659110394711     Document Type: Article

References (24)

1. Sade RM, Stroud MR, Crawford FA, Jr., Kratz JM, Dearing JP, Bartles DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thome Cardiovasc Surg 1985; 89: 713-722. (Pubitemid 16241964)
2. Chandler WL. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. J Cardiothorac Vase Anesth 2005; 19: 459-467. (Pubitemid 41112182)
3. Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjornskau L. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery. Thorac Cardiovasc Surg 1989; 37: 158-162. (Pubitemid 19165823)
4. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 2010; 104: 691-697.
5. Lilley A. The selection of priming fluids for cardiopulmonary bypass in the UK and Ireland. Perfusion 2002; 17: 315-319.
6. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vase Anesth 2001; 15: 316-321. (Pubitemid 32553378)
7. Van der Linden PJ, De Hert SG, Deraedt D, et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005; 101: 629-634. (Pubitemid 41208482)
8. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72: 527-533.
9. Palanzo DA, Parr GV, Bull AP, Williams DR, O'Neill MJ, Waldhausen JA. Hetastarch as a prime for cardiopulmonary bypass. Ann Thorac Surg 1982; 34: 680-683. (Pubitemid 13208211)
10. Sade RM, Crawford FA, Jr., Dearing JP, Stroud M. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1982; 84: 35-38. (Pubitemid 13099558)
11. Saunders CR, Carlisle L, Bick RL. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions. Ann Thorac Surg 1983; 36: 532-539. (Pubitemid 13022817)
12. Brinkman AC, Romijn JW, van Barneveld LJ, et al. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry. J Cardiothorac Vase Anesth 2010; 24: 422-426.
13. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006; 102: 998-1006.
14. Niemi TT, Kuitunen AH. Artificial colloids impair hae-mostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005; 49: 373-378. (Pubitemid 40432532)
15. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009; 108: 30-36.
16. Boldt J, Mengistu A. A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies. J Cardiothorac Vase Anesth 2010; 24: 394-398.
17. Casutt M, Kristoffy A, Schuepfer G, et al. Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM. Br J Anaesth 2010; 105: 273-281.
18. Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-310. (Pubitemid 40705054)
19. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth 2002; 89: 722-728. (Pubitemid 35277221)
20. Schramko AA, Kuitunen AH, Suojaranta-Ylinen RT, et al. Role of fibrinogen-, factor VIII- and XHI-mediated clot propagation in gelatin haemodilution. Acta Anaesthesiol Scand 2009; 53: 731-735.
21. Petroianu GA, Liu J, Maleck WH, et al. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on thrombelastograph. Anesth Analg 2000; 90: 795-800. (Pubitemid 30190780)
22. Fenger-Eriksen C, Tønnesen E, Ingerslev J, et al. Mechanisms of hydroxyethyl starch induced dilutional coagulopathy. J Thromb Haemost 2009; 7: 1099-1105.
23. Deusch E, Gamsjäger T, Kress HG, et al. Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003; 97: 680-683. (Pubitemid 37046426)
24. Theusinger OM, Nürnberg J, Asmis LM, Seifert B, Spahn DR. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg 2010; 37: 677-683.